PL2706982T3 - Donosowe farmaceutyczne postacie dawkowane zawierające nalokson - Google Patents

Donosowe farmaceutyczne postacie dawkowane zawierające nalokson

Info

Publication number: PL2706982T3
Authority: PL; Poland
Prior art keywords: dosage forms; pharmaceutical dosage; forms containing; nasal pharmaceutical; containing naloxone
Prior art date: 2011-05-13

Application number

PL12721507T

Other languages

English (en)

Inventor

John STRANG

Alexander Oksche

Stephen Harris

Kevin Smith

Lucie Helene Jeanne MOTTIER

Original Assignee

Euro-Celtique S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-13

Filing date

2012-05-11

Publication date

2018-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44658496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2706982(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-05-11 Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.

2018-07-31 Publication of PL2706982T3 publication Critical patent/PL2706982T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL12721507T 2011-05-13 2012-05-11 Donosowe farmaceutyczne postacie dawkowane zawierające nalokson PL2706982T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP11166076		2011-05-13
PCT/EP2012/058792 WO2012156317A2 (en)	2011-05-13	2012-05-11	Intranasal pharmaceutical dosage forms comprising naloxone
EP12721507.7A EP2706982B2 (en)	2011-05-13	2012-05-11	Intranasal pharmaceutical dosage forms comprising naloxone

Publications (1)

Publication Number	Publication Date
PL2706982T3 true PL2706982T3 (pl)	2018-07-31

Family

ID=44658496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12721507T PL2706982T3 (pl)	2011-05-13	2012-05-11	Donosowe farmaceutyczne postacie dawkowane zawierające nalokson

Country Status (37)

Country	Link
US (8)	US20150018379A1 (pl)
EP (2)	EP3320893A1 (pl)
JP (3)	JP6110367B2 (pl)
KR (2)	KR101873174B1 (pl)
CN (2)	CN107260672A (pl)
AR (1)	AR086391A1 (pl)
AT (1)	AT16553U1 (pl)
AU (2)	AU2012257785B2 (pl)
BR (1)	BR112013029126A2 (pl)
CA (1)	CA2835940C (pl)
CO (1)	CO6821959A2 (pl)
CY (1)	CY1120399T1 (pl)
DE (1)	DE202012013606U1 (pl)
DK (2)	DK2706982T4 (pl)
ES (1)	ES2661838T5 (pl)
HK (1)	HK1255428A1 (pl)
HR (1)	HRP20180233T1 (pl)
HU (1)	HUE036465T2 (pl)
IL (1)	IL229409B (pl)
LT (1)	LT2706982T (pl)
ME (1)	ME02958B (pl)
MX (1)	MX354249B (pl)
MY (1)	MY194947A (pl)
NO (1)	NO2706982T3 (pl)
PH (2)	PH12013502313A1 (pl)
PL (1)	PL2706982T3 (pl)
PT (1)	PT2706982T (pl)
RS (1)	RS57054B1 (pl)
RU (2)	RU2657441C1 (pl)
SG (1)	SG194927A1 (pl)
SI (1)	SI2706982T1 (pl)
SM (1)	SMT201800105T1 (pl)
TR (1)	TR201802716T4 (pl)
TW (1)	TWI486161B (pl)
UA (1)	UA110974C2 (pl)
WO (1)	WO2012156317A2 (pl)
ZA (1)	ZA201308280B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8627816B2 (en)	2011-02-28	2014-01-14	Intelliject, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en)	2011-01-26	2015-01-27	Kaleo, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
DK2706982T4 (da) *	2011-05-13	2021-05-10	Euro Celtique Sa	Intranasale farmaceutiske dosisformer omfattende naloxon
EP3082816B1 (en)	2013-12-20	2019-03-20	Indivior UK Limited	Intranasal naloxone compositions and methods of making and using same
US10085937B2 (en)	2014-03-14	2018-10-02	Adapt Pharma Limited	Nasal drug products and methods of their use
RU2020112530A (ru)	2014-03-14	2021-07-21	ОПИАНТ ФАРМАСЮТИКАЛС, Инк.	Назальные готовые лекарственные формы и способы их применения
US9480644B2 (en)	2014-03-14	2016-11-01	Opiant Pharmaceuticals, Inc.	Nasal drug products and methods of their use
US9561177B2 (en)	2014-03-14	2017-02-07	Adapt Pharma Limited	Nasal drug products and methods of their use
US10722510B2 (en)	2014-07-08	2020-07-28	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
US11135155B2 (en)	2014-07-08	2021-10-05	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
WO2016007729A1 (en) *	2014-07-09	2016-01-14	Lightlake Therapeutics Inc.	Co-packaged drug products
US9517307B2 (en)	2014-07-18	2016-12-13	Kaleo, Inc.	Devices and methods for delivering opioid antagonists including formulations for naloxone
US11559483B2 (en) *	2015-07-10	2023-01-24	Sanjay Gupta	Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
CA2950687C (en) *	2015-09-17	2023-02-28	Adapt Pharma Limited	Nasal drug products and methods of their use
US20190209464A1 (en) *	2016-06-24	2019-07-11	Opiant Pharmaceuticals, Inc.	Compositions, devices and methods for the treatment of alcohol use disorder
EP3500261A4 (en) *	2016-08-17	2020-05-06	Hikma Pharmaceuticals USA Inc.	LIQUID NALOXONE SPRAYING
EP3946547B1 (en) *	2019-03-26	2026-03-25	Pinova Therapeutics Inc.	Devices and methods for delivering pharmaceutical compositions
US10729687B1 (en)	2019-07-09	2020-08-04	Orexo Ab	Pharmaceutical composition for nasal delivery
US10653690B1 (en) *	2019-07-09	2020-05-19	Orexo Ab	Pharmaceutical composition for nasal delivery
WO2021158957A1 (en)	2020-02-05	2021-08-12	Summit Biosciences Inc.	Drug products for intranasal administration and uses thereof
US20230201369A1 (en) *	2020-04-29	2023-06-29	The Texas A&M University System	Naloxone nanoparticle compositions and methods thereof
SMT202200411T1 (it)	2020-05-18	2022-11-18	Orexo Ab	Nuova composizione farmaceutica per il rilascio controllato di farmaci
US11278709B1 (en)	2021-03-12	2022-03-22	Pocket Naloxone Corp.	Drug delivery device and methods for using same
MX2024001659A (es)	2021-08-04	2024-06-26	Indivior Inc	Composiciones y métodos para el tratamiento de la sobredosis por opioides.
AU2022395920A1 (en)	2021-11-25	2024-05-30	Orexo Ab	Pharmaceutical composition comprising adrenaline
GB202117016D0 (en)	2021-11-25	2022-01-12	Orexo Ab	New pharmaceutical device

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4464378A (en) *	1981-04-28	1984-08-07	University Of Kentucky Research Foundation	Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
GB9202464D0 (en)	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
US5866154A (en) *	1994-10-07	1999-02-02	The Dupont Merck Pharmaceutical Company	Stabilized naloxone formulations
US6608073B1 (en)	1998-10-14	2003-08-19	New Millennium Pharmaceutical Research, Inc.	Intranasal codeine for the rapid suppression of cough and rapid relief of pain
GB9908921D0 (en) *	1999-04-19	1999-06-16	Britannia Pharmaceuticals Ltd	Spray dispenser for opiod antagonists
JP2003501467A (ja)	1999-06-16	2003-01-14	ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド	鼻内モルヒネを含む医薬用製剤および方法
GB9924797D0 (en)	1999-10-20	1999-12-22	West Pharm Serv Drug Res Ltd	Compound
US6284765B1 (en)	2000-04-27	2001-09-04	The University Of North Texas Health Science Center At Fort Worth	(+) naloxone and epinephrine combination therapy
AU2001262992A1 (en) *	2000-05-10	2002-02-18	University Of Kentucky Research Foundation	System and method for intranasal administration of opioids
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
DE60133203T3 (de) *	2000-07-31	2012-02-23	Nycomed Danmark Aps	Fentanyl Zusammensetzung für nasale Anwendung
DE10064219B9 (de)	2000-12-22	2009-02-12	Nasalis Pain Relief International Gmbh	Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
US7666876B2 (en) *	2002-03-19	2010-02-23	Vernalis (R&D) Limited	Buprenorphine formulations for intranasal delivery
EP1535615A4 (en)	2002-07-11	2010-03-31	Taiho Pharmaceutical Co Ltd	COMPOSITION FOR THE NASAL ABSORPTION
GB0300531D0 (en)	2003-01-10	2003-02-12	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
CN1575795A (zh) *	2003-06-25	2005-02-09	中国人民解放军军事医学科学院毒物药物研究所	盐酸纳洛酮鼻腔喷雾剂
GB2403711A (en) *	2003-07-07	2005-01-12	Gw Pharma Ltd	Drug dispenser with controlled access
GB0400804D0 (en)	2004-01-14	2004-02-18	Innoscience Technology Bv	Pharmaceutical compositions
CN1726915B (zh) *	2004-07-27	2013-04-24	中国人民解放军军事医学科学院毒物药物研究所	盐酸纳洛酮鼻腔给药系统或组合物及其制备方法
WO2006016530A1 (ja)	2004-08-10	2006-02-16	Translational Research, Ltd.	速効性でかつ高い吸収性を可能とする経鼻投与用組成物
WO2006051448A2 (en) *	2004-11-09	2006-05-18	Koninklijke Philips Electronics N.V.	Array of spatial light modulators and method of production of a spatial light modulator device
ZA200704869B (en) *	2004-12-23	2009-02-25	Roxro Pharma Inc	Therapeutic compositions for intranasal administration of ketorolac
US8911751B2 (en)	2005-10-11	2014-12-16	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Compositions for nasal delivery
US20070212307A1 (en) *	2006-02-10	2007-09-13	Daniel Wermeling	Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
RU2344822C2 (ru) *	2006-04-05	2009-01-27	Алексей Валентинович Надеждин	Способ лечения героиновой наркомании
ES2652415T3 (es)	2006-12-26	2018-02-02	Shin Nippon Biomedical Laboratories, Ltd.	Preparación para aplicación transnasal
CN106389330A (zh) *	2007-01-19	2017-02-15	哈南亚有限公司	用于递送治疗剂的方法和组合物
WO2009040595A1 (en)	2007-09-28	2009-04-02	Wockhardt Research Centre	Multi-dose pharmaceutical composition of analgesic for nasal administration
DK2706982T4 (da) *	2011-05-13	2021-05-10	Euro Celtique Sa	Intranasale farmaceutiske dosisformer omfattende naloxon
EP3082816B1 (en)	2013-12-20	2019-03-20	Indivior UK Limited	Intranasal naloxone compositions and methods of making and using same
RU2020112530A (ru)	2014-03-14	2021-07-21	ОПИАНТ ФАРМАСЮТИКАЛС, Инк.	Назальные готовые лекарственные формы и способы их применения
US9480644B2 (en)	2014-03-14	2016-11-01	Opiant Pharmaceuticals, Inc.	Nasal drug products and methods of their use
US10085937B2 (en)	2014-03-14	2018-10-02	Adapt Pharma Limited	Nasal drug products and methods of their use
US9561177B2 (en)	2014-03-14	2017-02-07	Adapt Pharma Limited	Nasal drug products and methods of their use
US10617686B2 (en)	2014-07-08	2020-04-14	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray

2012
- 2012-05-11 DK DK12721507.7T patent/DK2706982T4/da active
- 2012-05-11 PT PT127215077T patent/PT2706982T/pt unknown
- 2012-05-11 SM SM20180105T patent/SMT201800105T1/it unknown
- 2012-05-11 HU HUE12721507A patent/HUE036465T2/hu unknown
- 2012-05-11 KR KR1020177001202A patent/KR101873174B1/ko active Active
- 2012-05-11 MX MX2013013276A patent/MX354249B/es active IP Right Grant
- 2012-05-11 SG SG2013083886A patent/SG194927A1/en unknown
- 2012-05-11 SI SI201231239T patent/SI2706982T1/en unknown
- 2012-05-11 TW TW101116857A patent/TWI486161B/zh not_active IP Right Cessation
- 2012-05-11 RS RS20180193A patent/RS57054B1/sr unknown
- 2012-05-11 TR TR2018/02716T patent/TR201802716T4/tr unknown
- 2012-05-11 US US14/084,551 patent/US20150018379A1/en not_active Abandoned
- 2012-05-11 EP EP17208976.5A patent/EP3320893A1/en not_active Withdrawn
- 2012-05-11 RU RU2016117731A patent/RU2657441C1/ru active
- 2012-05-11 AU AU2012257785A patent/AU2012257785B2/en active Active
- 2012-05-11 EP EP12721507.7A patent/EP2706982B2/en active Active
- 2012-05-11 NO NO12721507A patent/NO2706982T3/no unknown
- 2012-05-11 CN CN201710310253.2A patent/CN107260672A/zh active Pending
- 2012-05-11 ES ES12721507T patent/ES2661838T5/es active Active
- 2012-05-11 LT LTEP12721507.7T patent/LT2706982T/lt unknown
- 2012-05-11 AR ARP120101700A patent/AR086391A1/es unknown
- 2012-05-11 PL PL12721507T patent/PL2706982T3/pl unknown
- 2012-05-11 CA CA2835940A patent/CA2835940C/en active Active
- 2012-05-11 WO PCT/EP2012/058792 patent/WO2012156317A2/en not_active Ceased
- 2012-05-11 JP JP2014509762A patent/JP6110367B2/ja active Active
- 2012-05-11 AT ATGM50043/2018U patent/AT16553U1/de not_active IP Right Cessation
- 2012-05-11 HR HRP20180233TT patent/HRP20180233T1/hr unknown
- 2012-05-11 KR KR1020137032730A patent/KR101698182B1/ko active Active
- 2012-05-11 MY MYPI2018001495A patent/MY194947A/en unknown
- 2012-05-11 CN CN201280032034.8A patent/CN103764119A/zh not_active Withdrawn
- 2012-05-11 BR BR112013029126A patent/BR112013029126A2/pt not_active IP Right Cessation
- 2012-05-11 ME MEP-2018-35A patent/ME02958B/me unknown
- 2012-05-11 DE DE202012013606.2U patent/DE202012013606U1/de not_active Expired - Lifetime
- 2012-05-11 RU RU2013155479/15A patent/RU2587051C2/ru not_active IP Right Cessation
- 2012-05-11 PH PH1/2013/502313A patent/PH12013502313A1/en unknown
- 2012-11-05 UA UAA201314634A patent/UA110974C2/uk unknown
2013
- 2013-11-05 ZA ZA2013/08280A patent/ZA201308280B/en unknown
- 2013-11-12 IL IL229409A patent/IL229409B/en active IP Right Grant
- 2013-12-13 CO CO13291649A patent/CO6821959A2/es not_active Application Discontinuation
2015
- 2015-01-06 US US14/590,808 patent/US20150126540A1/en not_active Abandoned
2016
- 2016-01-14 JP JP2016005172A patent/JP2016128453A/ja active Pending
- 2016-07-05 PH PH12016501342A patent/PH12016501342A1/en unknown
- 2016-07-13 AU AU2016204880A patent/AU2016204880B2/en active Active
2017
- 2017-01-27 US US15/418,138 patent/US20170231904A1/en not_active Abandoned
- 2017-05-09 US US15/590,466 patent/US20170304192A1/en not_active Abandoned
2018
- 2018-02-26 CY CY20181100228T patent/CY1120399T1/el unknown
- 2018-04-19 DK DKBA201800034U patent/DK201800034U1/da not_active Application Discontinuation
- 2018-05-09 JP JP2018090275A patent/JP2018150336A/ja active Pending
- 2018-11-15 HK HK18114591.4A patent/HK1255428A1/en unknown
2019
- 2019-08-23 US US16/549,838 patent/US11020343B2/en active Active
2021
- 2021-04-23 US US17/238,509 patent/US11806428B2/en active Active
2023
- 2023-09-19 US US18/370,116 patent/US12458591B2/en active Active
2025
- 2025-10-10 US US19/355,540 patent/US20260108456A1/en active Pending

Also Published As

Publication number	Publication date
HK1255428A1 (en)	2019-08-16
PH12016501342B1 (en)	2018-06-11
EP3320893A1 (en)	2018-05-16
US20170231904A1 (en)	2017-08-17
IL229409B (en)	2020-10-29
DE202012013606U1 (de)	2018-04-18
IL229409A0 (en)	2014-01-30
ME02958B (me)	2018-07-20
UA110974C2 (uk)	2016-03-10
TR201802716T4 (tr)	2018-03-21
US20150126540A1 (en)	2015-05-07
EP2706982B1 (en)	2018-01-03
US20240082149A1 (en)	2024-03-14
BR112013029126A2 (pt)	2017-02-07
US11806428B2 (en)	2023-11-07
NO2706982T3 (pl)	2018-06-02
PT2706982T (pt)	2018-03-08
EP2706982A2 (en)	2014-03-19
AU2012257785A1 (en)	2013-11-28
AU2016204880A1 (en)	2016-07-28
EP2706982B2 (en)	2021-03-10
JP6110367B2 (ja)	2017-04-05
CN107260672A (zh)	2017-10-20
SG194927A1 (en)	2013-12-30
DK201800034U1 (da)	2018-05-25
MY194947A (en)	2022-12-27
US20210338574A1 (en)	2021-11-04
MX2013013276A (es)	2014-08-07
PH12013502313A1 (en)	2022-04-08
US20260108456A1 (en)	2026-04-23
US20150018379A1 (en)	2015-01-15
DK2706982T4 (da)	2021-05-10
PH12016501342A1 (en)	2018-06-11
WO2012156317A3 (en)	2013-05-10
US11020343B2 (en)	2021-06-01
TWI486161B (zh)	2015-06-01
JP2014513683A (ja)	2014-06-05
RU2587051C2 (ru)	2016-06-10
NZ617442A (en)	2015-03-27
CN103764119A (zh)	2014-04-30
RS57054B1 (sr)	2018-05-31
AR086391A1 (es)	2013-12-11
US20190374464A1 (en)	2019-12-12
ES2661838T3 (es)	2018-04-04
CA2835940A1 (en)	2012-11-22
KR101873174B1 (ko)	2018-06-29
DK2706982T3 (en)	2018-03-12
CY1120399T1 (el)	2019-07-10
TW201311244A (zh)	2013-03-16
ES2661838T5 (es)	2021-11-18
JP2016128453A (ja)	2016-07-14
CO6821959A2 (es)	2013-12-31
KR101698182B1 (ko)	2017-01-19
RU2013155479A (ru)	2015-06-20
LT2706982T (lt)	2018-05-25
KR20140007482A (ko)	2014-01-17
AU2016204880B2 (en)	2017-11-23
US20170304192A1 (en)	2017-10-26
HRP20180233T1 (hr)	2018-06-01
NZ705933A (en)	2016-07-29
AU2012257785B2 (en)	2016-04-14
MX354249B (es)	2018-02-20
HUE036465T2 (hu)	2018-07-30
KR20170010078A (ko)	2017-01-25
JP2018150336A (ja)	2018-09-27
SI2706982T1 (en)	2018-05-31
US12458591B2 (en)	2025-11-04
AT16553U1 (de)	2020-01-15
SMT201800105T1 (it)	2018-05-02
CA2835940C (en)	2020-08-04
RU2657441C1 (ru)	2018-06-13
WO2012156317A2 (en)	2012-11-22
ZA201308280B (en)	2014-07-30

Publication	Publication Date	Title
IL229409B (en)	2020-10-29	Intranasal pharmaceutical dosage forms comprising naloxone
DK2768559T3 (da)	2023-09-18	Lægemiddelindgivelsesanordning
EP2748685A4 (en)	2015-05-20	PORTABLE MEDICINAL DISPENSER
DK2665503T3 (da)	2024-02-12	Medikamenttilførselsanordning
IL239527A0 (en)	2015-08-31	Medicament delivery device
PL2817052T3 (pl)	2018-01-31	Urządzenia do podawania donosowego
CO6852076A2 (es)	2014-01-30	Composiciones farmacéuticas inhalables
EP3895747C0 (en)	2025-12-24	DRUG ADMINISTRATION DEVICE
PL2922526T3 (pl)	2022-01-03	Wytwarzanie półplastycznych farmaceutycznych jednostek dawkowania
SMT201500232B (it)	2015-10-30	Dispositivo per la somministrazione de farmaci
EP2709645A4 (en)	2015-02-18	ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
DK2740504T3 (da)	2020-11-16	Lægemiddelfremføringsanordning
IL230838A0 (en)	2014-03-31	Pharmaceutical compositions
CO6940426A2 (es)	2014-05-09	Formulaciones farmacéuticas
IL231622B (en)	2018-10-31	Pharmaceutical composition for treatment of cachexia
HUE049942T2 (hu)	2020-11-30	Inozitolt tartalmazó gyógyszerészeti formuláció
HUE039907T2 (hu)	2019-02-28	Gyógyszer-szállító technológia
DK3143998T3 (da)	2019-06-17	Inhalerbart lægemiddel omfattende tiotropium
DK3335753T3 (da)	2020-11-09	Dispenser med dosistæller
BR112014015885A8 (pt)	2017-07-04	preparação farmacêutica
BR112014009319A2 (pt)	2017-05-30	compostos farmacêuticos
HRP20180567T1 (hr)	2018-05-18	Farmaceutski pripravak omeprazola
EP2769718A4 (en)	2015-07-01	MEDICAL COMPOSITION
ZA201405797B (en)	2015-08-26	Pharmaceutical dosage form
IL233350A0 (en)	2014-08-31	Inhalation device for powdered drugs